Wednesday, October 8, 2025

Latest

Champignon Brands Appoints Dr Joseph Gabriele To Special Advisory Committee

Champignon Brands (CSE: SHRM) this morning announced that it is bolstering its special advisory committee through the appointment of Dr Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system.

Gabriele is expected to be responsible for championing Champignon’s development and commercialization of rapid onset treatments which are capable of improving health outcomes. The special advisory committee as a whole is expected to evaluate potential positive effects that its medicinal mushroom formulations may have on individuals suffering from depression or post traumatic stress disorder, as well as substance and alcohol use disorders.

Gabriele himself is specialized in molecular pharmacology, transdermal delivery, and formulation chemistry with pharmaceutical, natural molecules. Most recently he lead Delivra, which was later acquired by Harvest One Cannabis (TSXV: HVT), where he developed a transdermal delivery platform that can be tailored to deliver drugs via the skin to the skin derma, circulatory system, or muscles.

Dr. Gabriele’s established research credentials, entrepreneurial nature and relentless pursuit of medical innovation represents the desired skill sets that Champignon needs as we accelerate our accession into the psychedelic medicine arena. The appointment of Dr. Gabriele equips us with both a celebrated medical researcher, as well as a seasoned CPG formulation specialist, which will allow for the continued development of our mushroom-infused health products, novel delivery systems and eventual drug discovery initiatives.

Gareth Birdsall, CEO of Champignon Brands

Champignon Brands last traded at $0.30 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Harvest Moon: Reducing Suicidal Ideation With Ketamine Infusions

Suicidal ideation is an emergent condition that demands immediate attention. It has been shown that...

Tuesday, May 26, 2020, 03:00:00 PM

Champignon Brands To Resume Trading Today

Champignon Brands (CSE: SHRM) is expected to resume trading today after what was a nearly...

Friday, April 23, 2021, 08:22:55 AM

Champignon Closes AltMed Transaction, Partners With Leading Canadian Pharmacy

Champignon Brands (CSE: SHRM) today announced that it has partnered with a major pharmacy chain...

Thursday, April 30, 2020, 03:56:06 PM

Braxia Scientific Launches Multiple-Dose Psilocybin Clinical Trial for Treatment-Resistant Depression

Braxia Scientific Corp. (CSE: BRAX), formerly Champignon Brands, announced today that its clinical research and...

Friday, August 27, 2021, 08:20:00 AM

Champignon Brands Files Required Disclosures With Exchange, Resumption Of Trading In Hands Of BCSC

Champignon Brands (CSE: SHRM) has completed the regulatory filings required as per the review previously...

Friday, July 24, 2020, 05:33:15 PM